More than $800,000 in grants from foundations backed by Bill Gates and Paul Allen will help speed development of Corgenix Medical Corp.’s quick Ebola diagnostic test.
The Bill & Melinda Gates Foundation and the Paul G. Allen Family Foundation last week awarded a combined $818,000 in grants that will allow Corgenix to launch a clinical trial next month in Sierra Leone, which remains a hotbed for the deadly virus, to apply for regulatory approval and to build an inventory to distribute the tests into the field.
“It allows us to accelerate it at its maximum level and get products out there now,” Corgenix CEO Douglass Simpson said.
The grants complement a three-year $2.9 million grant to Broomfield-based Corgenix from the National Institutes of Health in June that did not cover clinical trials and regulatory submittals, Simpson said.
Read more of the article at DailyCamera.com.
